Danielle Kirsh

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies, opening pathways for increased patient access to these hypertension treatments on January 1, 2025.

Hexagon Health and its founder have filed a lawsuit against Medtronic, alleging patient infringement of a hernia mesh device.

Three major investors are calling on Smith+Nephew to explore breaking up parts of its business with a focus on potentially spinning off its orthopedics division, Financial Times reports.

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

iRhythm Technologies today announced new research emphasizing the clinical and health-economic advantages of its Zio long-term continuous monitoring (LTCM) system.

GE HealthCare ’s Portrait Mobile continuous monitoring solution is redefining post-surgical care, according to a new study published in the Journal of Clinical Anesthesia.

Nevro recently announced its Nevro1 SI Joint Fusion System has been shown to outperform traditional surgical approaches in stabilizing the sacroiliac (SI) joint and promote long-term fusion. The research, published in Medical Devices: Evidence and Research, highlights Nevro1’s ability to reduce motion, enhance fusion potential, and minimize invasiveness, making it a groundbreaking option for patients […]

Henry Schein today announced it signed an agreement to acquire Acentus, a national supplier of home care medical products.

By Danielle Kirsh Leave a Comment The FDA will discuss a new framework for regulating generative artificial intelligence (GenAI)-enabled devices during a Digital Health Advisory Committee meeting this week.

By Danielle Kirsh Leave a Comment Abbott has released a comprehensive report, Advancing Diversity in Clinical Trials, marking the third year of its multi-million-dollar Diversity in Clinical Trials initiative.